Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report by Yu-Chien Lin, Kuo-Chang Wen, Pi-Lin Sung, Yu-Ting Chou, Phui-Ly Liew, Lin-Yu Chen, Rui-Lan Huang, Hung-Cheng Lai, Lu-Te Chang

Subjects: “…Angiogenesis inhibitor…”
Get full text

Development of a Pulmonary Arteriovenous Fistula after a Modified Glenn Shunt in Tetralogy of Fallot and Its Resolution after Shunt Takedown in a 57-Year-Old Patient by Sang Yoon Kim, Eung Rae Kim, Ji Hyun Bang

Subjects: Get full text

Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient by Camillo Porta, Camillo Porta, Alessandra Ferrari, Anna M. Czarnecka, Cezary A. Szczylik

Subjects: “…angiogenesis inhibitor…”
Get full text

Coronary angiogenesis during experimental hypertension: Is it reversible? by Mohammad Zarei, Majid Khazaei, Mohammad Reza Sharifi, Ali Asghar Pourshanazari

Subjects: Get full text

Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma by Thi Bich Uyen Le, Thanh Chung Vu, Rebecca Zhi Wen Ho, Aldo Prawira, Lingzhi Wang, Boon Cher Goh, Hung Huynh

Subjects: Get full text

BAI1 nuclear expression reflects the survival of nonsmoking non‐small cell lung cancer patients by Hyo Jung An, Sung Hwan Kim, Jung Wook Yang, Min Hye Kim, Hye Jin Baek, Kyeong Hwa Ryu, Kyung Nyeo Jeon, Chang Sup Lee, Jun Young Choi, Dae Hyun Song

Subjects: “…brain‐specific angiogenesis inhibitor 1…”
Get full text

A Case Report of Ischemic Stroke in a Patient with Metastatic Gastric Cancer Secondary to Treatment with the Vascular Endothelial Growth Factor Receptor-2 Inhibitor Ramucirumab by Michael E. Christiansen, Timothy Ingall, Edward C. Lew, Ramesh K. Ramanathan, Harshita R. Paripati

Subjects: Get full text

TP53 status is associated with thrombospondin1 expression in vitro by Angeles eAlvarez Secord, Marcus Q Bernardini, Gloria eBroadwater, Lisa A Grace, Zhiqing eHuang, Tsukasa eBaba, Eiji eKondo, Gregory eSfakianos, Laura J Havrilesky, Susan K Murphy

Subjects: “…Angiogenesis Inhibitors…”
Get full text

Bevacizumab, a vascular endothelial growth factor inhibitor, promotes orthodontic tooth movement in an experimental rat model by Hatem Abuohashish, Abdulaziz Alamri, Suliman Shahin, Dalal Almazrou, Taleb Alkhamis, Omar Omar

Subjects: “…Angiogenesis inhibitors…”
Get full text

Fotocoagulación panretinal y bevacizumab intravítreo en el tratamiento de la retinopatía diabética proliferativa activa by Arianna Hernández Pérez, Oslay Mijail Tirado Martínez

Subjects: Get full text

Efficacy and Safety of Anlotinib in Overall and Disease-Specific Advanced Gynecological Cancer: A Real-World Study by Hong X, Qiu S, Wu X, Chen S, Chen X, Zhang B, He A, Xu Y, Wang J, Gao Y, Xu X, Sun L, Zhang Y, Xiang L, Zhou J, Guan Q, Zhu Y, Liu H, Xu H, Zhou Y, Chen B, Shen Y

Subjects: Get full text

Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance by Bahare Zarrin, Farzane Zarifi, Golnaz Vaseghi, Shaghayegh Haghjooy Javanmard

Subjects: “…Angiogenesis inhibitors…”
Get full text

Inhibition of EGF and CoCl2-Induced HIF-1α and VEGF Production in Triple Negative MDA-MB-468 Cells by Umbelliprenin: Unveiling the Role of PI3K/AKT/mTOR and MAPK Pathways by Roya Atabakhshian, Melina Moshirpour, Mohammad Hadi Farjoo, Shiva Ghafghazi, Seyed Ali Ziai*

Subjects: “…angiogenesis inhibitors…”
Get full text

Efficacy and safety of bevacizumab in patients with malignant melanoma: a systematic review and PRISMA-compliant meta-analysis of randomized controlled trials and non-comparative c... by Xiao Han, Xiao Han, Pu Ge, Siyu Liu, Dandan Yang, Jinzi Zhang, Xinpei Wang, Weiting Liang

Subjects: Get full text

Marine Cyanobacteria as Sources of Lead Anticancer Compounds: A Review of Families of Metabolites with Cytotoxic, Antiproliferative, and Antineoplastic Effects by Benjamín Robles-Bañuelos, Lorena María Durán-Riveroll, Edgar Rangel-López, Hugo Isidro Pérez-López, Leticia González-Maya

Subjects: “…angiogenesis inhibitor…”
Get full text

Osimertinib and Bevacizumab Cotreatment for Untreated EGFR-Mutated NSCLC With Malignant Pleural or Pericardial Effusion (SPIRAL II): A Single-Arm, Open-Label, Phase 2 Clinical Tria... by Makoto Hibino, MD, Osamu Hiranuma, MD, Yoshizumi Takemura, MD, PhD, Yuki Katayama, MD, Yusuke Chihara, MD, PhD, Taishi Harada, MD, Kohei Fujita, MD, PhD, Toshiyuki Kita, MD, PhD, Nobuyo Tamiya, MD, PhD, Takeshi Tsuda, MD, Shinsuke Shiotsu, MD, Yukihiro Tamura, MD, PhD, Takashi Aoyama, MD, Yoichi Nakamura, MD, PhD, Masaaki Terashima, MD, PhD, Yoshie Morimoto, MD, PhD, Kazuhiro Nagata, MD, PhD, Kenichi Yoshimura, PhD, Junji Uchino, MD, PhD, Koichi Takayama, MD, PhD

Subjects: “…Angiogenesis inhibitor…”
Get full text

Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy by Hong-My Nguyen, Kirsten Guz-Montgomery, Dipongkor Saha

Subjects: Get full text

Tumor angiogenesis regulators / by Gonzalez-Perez, Ruben R editor, Rueda, Bo R editor

Subjects:

A case report of endorectal displacement of a right ureteral stent following radiochemotherapy and Bevacizumab by Alessio Tognarelli, Lorenzo Faggioni, Francesca Manassero, Angiolo Gadducci, Cesare Selli

Subjects: Get full text

Use of ranibizumab for the treatment of subretinal neovascularization in pathologic myopia: a prospective study by О.M. Blavatska, T.B. Kustry, A.R. Korol

Subjects: Get full text